Therefore, 3c was selected as the lead compound that acted as an AChE inhibitor binding to the peripheric active site of this enzyme and that fulfilled one of the most important requirements in discovery of drugs for AD—it crosses the BBB. The gene discussed is ACHE; the disease is Alzheimer disease.